Stocks · Health care · Pharmaceutical Preparations

Seres Therapeutics, Inc.

MCRB Clue Score46
United States Fiscal year ends December CIK 0001609809 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Matthew R Henn
15 Feb 2026
See Remarks
Sold after exercise
89
$8.47
$753.83
Thomas DesRosier
15 Feb 2026
See Remarks
Sold after exercise
78
$8.47
$660.66
Teresa L. Young
15 Feb 2026
See Remarks
Sold after exercise
75
$8.47
$635.25
Eric D. Shaff
15 Feb 2026
Director
Sold after exercise
259
$8.47
$2.19K
Matthew R Henn
15 Nov 2025
See Remarks
Sold after exercise
1,257
$17.30
$21.75K
Thomas DesRosier
15 Nov 2025
See Remarks
Sold after exercise
76
$17.30
$1.31K
Eric D. Shaff
15 Nov 2025
Director
Sold after exercise
217
$17.30
$3.75K
Teresa L. Young
15 Nov 2025
See Remarks
Sold after exercise
1,042
$17.30
$18.03K
Thomas DesRosier
15 May 2025
Chief Legal Officer and EVP
Sold after exercise
79
$7.28
$575.12
Thomas DesRosier
15 May 2024
Chief Legal Officer and EVP
Sold after exercise
843
$0.94
$792.42
David S. Ege
15 May 2024
See Remarks
Sold after exercise
1,090
$0.94
$1.02K
Matthew R Henn
15 May 2024
See Remarks
Sold after exercise
891
$0.94
$837.54
Teresa L. Young
15 May 2024
See Remarks
Sold after exercise
703
$0.94
$660.82
Eric D. Shaff
15 May 2024
CEO and President
Sold after exercise
2,435
$0.94
$2.29K
Moltke Lisa von
15 May 2024
See Remarks
Sold after exercise
939
$0.94
$882.66
Matthew R Henn
1 Dec 2020
See Remarks
Sold after exercise
9,841
$28.34
$278.89K
Matthew R Henn
1 Dec 2020
See Remarks
Sold after exercise
26,265
$27.56
$723.86K
Matthew R Henn
1 Dec 2020
See Remarks
Sold after exercise
55,706
$26.56
$1.48M
Roger Pomerantz
11 Jul 2018
President and CEO
Sold after exercise
1,010
$9.01
$9.10K
Roger Pomerantz
10 Jul 2018
President and CEO
Sold after exercise
5,989
$9.05
$54.21K
Roger Pomerantz
9 Jul 2018
President and CEO
Sold after exercise
10,981
$9.14
$100.35K
Roger Pomerantz
6 Jul 2018
President and CEO
Sold after exercise
15,366
$9.14
$140.51K
Roger Pomerantz
29 Jun 2018
President and CEO
Sold after exercise
4,496
$9.10
$40.92K
Roger Pomerantz
28 Jun 2018
President and CEO
Sold after exercise
21,560
$9.15
$197.38K
Roger Pomerantz
27 Jun 2018
President and CEO
Sold after exercise
16,991
$9.03
$153.41K
Roger Pomerantz
26 Jun 2018
President and CEO
Sold after exercise
21,224
$9.19
$195.13K
Roger Pomerantz
25 Jun 2018
President and CEO
Sold after exercise
26,752
$9.21
$246.50K
David N Cook
26 Jan 2018
See Remarks
Sold after exercise
1,738
$11.02
$19.15K
Michele Trucksis
26 Jan 2018
See Remarks
Sold after exercise
2,607
$11.02
$28.73K
Thomas DesRosier
26 Jan 2018
See Remarks
Sold after exercise
3,475
$11.02
$38.29K
Eric D. Shaff
26 Jan 2018
See Remarks
Sold after exercise
2,780
$11.02
$30.64K
John G. Aunins
26 Jan 2018
See Remarks
Sold after exercise
1,738
$11.02
$19.15K
John G. Aunins
19 Dec 2017
Chief Technology Officer & EVP
Sold after exercise
1,623
$10.14
$16.46K

What was left out

Form 4 filings counted 278
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 51
Sales straight out of an exercise 33
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 9,854,506
Sales filed before the plan box existed 20
History held since 29 Jun 2015